Close Menu

Oxford Nanopore's announcement of its new whole-genome sequencing technology has set the genomics world talking once again about the $1,000 genome and how it could change research and healthcare. It "has the promise of taking the enterprise of sequencing an individual's genome out of the basic science laboratory, and out to the consumer mass market," says Razib Khan at The Crux blog.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK has given emergency authorization for Pfizer and BioNTech's SARS-CoV-2 vaccine, the Associated Press reports.

A US advisory committee says healthcare workers and nursing home residents should be prioritized to receive a SARS-CoV-2 vaccine, according to the Financial Times.

The Wall Street Journal reports North Korean hackers have targeted half a dozen companies developing SARS-CoV-2 vaccines.

In Cell this week: long-term SARS-CoV-2 shedding, examination of the effects of a coronavirus spike protein mutation, and more.